Myasthenia Gravis
Article
Placing New Therapies for Myasthenia Gravis in the Treatment Paradigm
New complement inhibitors are shifting the paradigm for myasthenia gravis...
Article
Don't Miss the Dx: A 63-Year-Old Man With Proptosis, Diplopia, and Upper-Body Weakness
Are you familiar with the presentation, differential diagnosis, and workup for generalized myasthenia gravis? Dr Christopher Luzzio provides a...
Fact or Fiction: Generalized Myasthenia Gravis
Can you separate fact from fiction when it comes to generalized myasthenia gravis? Test your knowledge with this quiz.
Rapid Review Quiz: Generalized Myasthenia Gravis Management
How much do you know about the most recent developments in generalized myasthenia gravis management? Test your knowledge with this quick quiz.
Commentary
Myasthenia Gravis: 5 Things to Know
Article
Myasthenia Gravis: Treating the Whole Patient
In the evolving landscape of myasthenia gravis treatment, Dr Nicholas Silvestri urges early-career professionals to address the broader impact of...
Article
Myasthenia Gravis: 3 Tips to Improve Patient-Centered Care
Dr Kelly G. Gwathmey advises early-career clinicians, emphasizing attentive listening to patients and promoting shared decision-making in...
Article
Myasthenia Gravis: Reflections on Past Challenges and Evolving Strategies
Dr Nicholas Silvestri shares an experience from early neurology residency, addressing the diagnostic and treatment journey of a patient.
Article
Inspiring Encounters in the Treatment of Myasthenia Gravis
Dr Kelly G. Gwathmey reflects on how early experience in the study of neurology shaped a path to the study of myasthenia gravis.
Article
Myasthenia Gravis: Lessons on a Comprehensive Approach to Patient Care
Dr Nicholas J. Silvestri expresses deep appreciation for mentorship, particularly from Dr Chip Howard, a renowned figure in myasthenia gravis.
Article
Myasthenia Gravis: A Mentor's Emphasis on Patient-Centered Outcomes
Dr Kelly G. Gwathmey reflects on her training under important mentors during her clinical training.